Add to MyYahoo RSS

Pharmaceutical News

Pharmaceuticals news continually updated from thousands of sources around the net.

10 hrs ago |

The Real Health Care Subsidy Problem

People have criticized The Affordable Care Act for amounting to a large transfer of wealth, from wealthy Americans to those not as well off.


Related Topix: Healthcare Industry

14 hrs ago | The Daily Star

Drug industry insiders allege dubious practices in sector

BEIRUT: Pharmaceutical industry insiders say dubious business practices are widespread in the Lebanon's drugs sector following an announcement by a British company that it was investigating bribery allegations in Jordan and Lebanon.


Related Topix: Medicine

15 hrs ago | BioSpace

PharMerica Announces First Quarter 2014 Earnings Call And Webcast

PharMerica Corporation announced today that it will provide an online webcast of its first quarter 2014 earnings conference call on Thursday, May 1, 2014.


Related Topix: Biotech, PharMerica, Medicine, Healthcare Industry

20 hrs ago | Pharmaceutical Processing

Actavis to Acquire Four Products from Akorn

Actavis has entered into agreements with Akorn and Hi-Tech Pharmacal to purchase four currently marketed products and one product under development for cash consideration.The closing of the purchase agreements are contingent upon the consummation of Akorn's acquisition of Hi-Tech.


Related Topix: Biotech, Medicine, HiTech Pharmacal Co, Healthcare Industry

Yesterday | Reuters

UPDATE 1-Teva willing to post bond to suspend decision on Copaxone

Teva Pharmaceutical Industries Ltd on Thursday told the U.S. Supreme Court that it is willing to post up to a $500 million bond in return for a decision suspending a lower court ruling that would allow generic competitors to go on the market as soon as next month.


Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry, US News, US Supreme Court, Federal Circuit Court of Appeals

Yesterday | BioSpace

Thomson Reuters Names 2014 Drugs To Watch

The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, released its annual forecast of the leading drugs to watch in 2014, including three potential blockbuster treatments anticipated to attain more than $1 billion in sales through 2019, after ... (more)


Related Topix: Hepatitis, Medicine, Health, Healthcare Law, Law, Lymphoma, Leukemia

Thu Apr 17, 2014

Business Journal

Prosonix reaches licensing agreement with Mylan Inc.

Prosonix, an innovative specialty pharmaceutical company based in England, has announced a global licensing agreement for its inhaled respiratory products with Mylan Inc. , the Canonsburg-based generic drug giant.


Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Dey, Startups, Fluticasone (generic), Flovent, Asthma, Health

Business Journal

MedSnap has prescription for the pharmaceutical industry

When Wired Magazine featured Birmingham's MedSnap in a story last year, CEO Patrick Hymel probably didn't imagine the article would end up leading to a whole new aspect to the company's business.



UPDATE 1-Teva, Pfizer settle patent lawsuit over blockbuster painkiller

Teva Pharmaceutical Industries Ltd said it settled a patent lawsuit with Pfizer Inc, allowing the Israeli drugmaker to launch a generic version of Pfizer's blockbuster painkiller Celebrex in December.


Related Topix: Pfizer, Biotech, Medicine, Healthcare Industry, Teva Pharmaceutical Industries, Celebrex, Celecoxib (generic), Arthritis, Health, Pain

Business Wire

View Press Release

The combination of Akorn and Hi-Tech will transform the Company into a larger, more diversified generic player.


Related Topix: Biotech, Medicine, Akorn, Healthcare Industry, HiTech Pharmacal Co, Marketing, Somerset, NJ

Mail & Guardian

The science behind dietary supplements

From multivitamins to fish oil, daily pills and powders have become routine for millions around the world.


Related Topix: Supplement, Fish Oil, Biotech, D and K Healthcare Resources, Medicine, Healthcare Industry, Nutrition, EPA, DHA


IMPAX Laboratories, Inc. Launches Authorized Generic RENVELA

RENVELA is indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis.


Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Startups, Renagel, Sevelamer (generic), Healthcare Law, Food and Drug Administration, Law, Marketing

Wed Apr 16, 2014


Mylan Launches First Generic Ortho Evra Patch

Mylan Inc. today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched XULANE , the generic version of Janssen Pharmaceuticals Inc.'s ORTHO EVRA * .


Related Topix: Biotech, Medicine, Mylan Laboratories, Healthcare Industry, Dey, Startups, Ortho Evra, Norelgestromin/Ethinyl Estradiol (generic), Food and Drug Administration


Jackson Puts Statewide Drug Take-Back Legislation on Hold

State Sen. Hannah-Beth Jackson , D-Santa Barbara, announced on Wednesday that, due to a lack of support from some of her legislative colleagues in the Senate Business, Professions and Economic Development Committee, she is shelving a bill this year to create the nation's first statewide drug take-back program for prescription and over-the-counter ... (more)


Related Topix: Santa Barbara, CA, Alameda County, CA

Impax Laboratories Receives New Coverage from Analysts at Sterne Agee

Other equities research analysts have also recently issued reports about the stock.


Related Topix: Biotech, Impax Laboratories, Medicine, Healthcare Industry, Startups

Sterne Agee Initiates Coverage on Teva Pharmaceutical Industries Ltd

The firm set a "neutral" rating on the stock. TEVA has been the subject of a number of other recent research reports.


Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Healthcare Industry

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Research and Markets: Global Testicular Cancer Drugs Market 2014-2018 With Bristol-Myers Squibb, Hospira, Teva Pharmaceutical Industries & ZIOPHARM Oncology Dominating )--Research and Markets has announced the addition of the "Global Testicular Cancer Drugs Market 2014-201... )--Research and Markets has announced the addition of the "Global ... (more)


Related Topix: Biotech, Teva Pharmaceutical Industries, Medicine, Cephalon, Healthcare Industry, SAS, Functional, Inc, Cameras

Parliament clears a 3 billion EU medicines R&D initiative

The European Parliament voted in favour of the second Innovative Medicines Initiative on Tuesday , a multi-billion Euro research programme run jointly by the European Commission and the pharmaceutical industry.


Tue Apr 15, 2014

Samsung Pharmaceutical Industry Corporation Limited (001360) -...

The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats.


Sys-Con Media

Repligen Corporation Set to Join the S&P SmallCap 600

S&P SmallCap 600 constituent Akorn Inc. is acquiring Hi-Tech Pharmacal Co. in a deal expected to be completed soon.


Related Topix: Repligen, Biotech, Medicine, Healthcare Industry, HiTech Pharmacal Co, Akorn, Financial Markets


Pharmaceuticals Jobs